RHUMBLINE ADVISERS - ALEXION PHARMACEUTICALS CVR ownership

ALEXION PHARMACEUTICALS CVR's ticker is and the CUSIP is 015CVR109. A total of 1 filers reported holding ALEXION PHARMACEUTICALS CVR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ALEXION PHARMACEUTICALS CVR
ValueSharesWeighting
Q3 2023$0113,6830.0%0.00%
Q2 2023$0113,683
-0.2%
0.00%
Q1 2023$0113,8730.0%0.00%
Q4 2022$0113,8730.0%0.00%
Q3 2022$0113,8730.0%0.00%
Q2 2022$0113,8730.0%0.00%
Q1 2022$0113,8730.0%0.00%
Q4 2021$0113,8730.0%0.00%
Q3 2021$0113,8730.0%0.00%
Q2 2021$0113,873
-11.0%
0.00%
Q1 2021$0127,930
-33.4%
0.00%
Q4 2020$0191,9950.0%0.00%
Q3 2020$0191,995
-13.5%
0.00%
Q2 2020$0222,0710.0%0.00%
Q1 2020$0222,0710.00%
Other shareholders
ALEXION PHARMACEUTICALS CVR shareholders Q4 2020
NameSharesValueWeighting ↓
RHUMBLINE ADVISERS 191,995$00.00%
View complete list of ALEXION PHARMACEUTICALS CVR shareholders